Diagnosis and management of ADHD in children
- PMID: 25369623
Diagnosis and management of ADHD in children
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is the most common behavioral disorder in children, and the prevalence is increasing. Physicians should evaluate for ADHD in children with behavioral concerns (e.g., inattention, hyperactivity, impulsivity, oppositionality) or poor academic progress using validated assessment tools with observers from several settings (home, school, community) and self-observation, if possible. Physicians who inherit a patient with a previous ADHD diagnosis should review the diagnostic process, and current symptoms and treatment needs. Coexisting conditions (e.g., anxiety, learning, mood, or sleep disorders) should be identified and treated. Behavioral treatments are recommended for preschool-aged children and may be helpful at older ages. Effective behavioral therapies include parent training, classroom management, and peer interventions. Medications are recommended as first-line therapy for older children. Psychostimulants, such as methylphenidate and dextroamphetamine, are most effective for the treatment of core ADHD symptoms and have generally acceptable adverse effect profiles. There are fewer supporting studies for atomoxetine, guanfacine, and clonidine, and they are less effective than the psychostimulants. Height, weight, heart rate, blood pressure, symptoms, mood, and treatment adherence should be recorded at follow-up visits.
Similar articles
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Attention-deficit hyperactivity disorder.Clin Pharm. 1990 Aug;9(8):632-42. Clin Pharm. 1990. PMID: 1974836 Review.
-
Attention-deficit-hyperactivity disorder: an update.Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Pharmacotherapy. 2009. PMID: 19476419 Review.
-
[Prescribing ritalin in combined modality management of hyperactivity with attention deficit].Encephale. 2001 Sep-Oct;27(5):435-43. Encephale. 2001. PMID: 11760693 French.
-
Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.Encephale. 2020 Feb;46(1):30-40. doi: 10.1016/j.encep.2019.06.005. Epub 2019 Oct 11. Encephale. 2020. PMID: 31610922 Review.
Cited by
-
Towards a neurodevelopmental model of bipolar disorder: a critical review of trait- and state-related functional neuroimaging in adolescents and young adults.Mol Psychiatry. 2024 Sep 27. doi: 10.1038/s41380-024-02758-4. Online ahead of print. Mol Psychiatry. 2024. PMID: 39333385 Review.
-
Neurodevelopmental disorders in children seeking obesity treatment- associations with intellectual ability and psychiatric conditions.Front Psychiatry. 2024 Aug 19;15:1332598. doi: 10.3389/fpsyt.2024.1332598. eCollection 2024. Front Psychiatry. 2024. PMID: 39224476 Free PMC article.
-
A Comparison of Effectiveness of Attention Process Training (APT) with Parenting Management Training (PMT) in Reducing Symptoms of Attention Deficit Hyperactivity Disorder.Iran J Psychiatry. 2024 Jul;19(3):254-264. doi: 10.18502/ijps.v19i3.15802. Iran J Psychiatry. 2024. PMID: 39055521 Free PMC article.
-
Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies.Front Nutr. 2024 May 2;11:1389374. doi: 10.3389/fnut.2024.1389374. eCollection 2024. Front Nutr. 2024. PMID: 38757130 Free PMC article. Review.
-
Neuropsychiatric Aspects of Sotos Syndrome: Explorative Review Building Multidisciplinary Bridges in Clinical Practice.J Clin Med. 2024 Apr 11;13(8):2204. doi: 10.3390/jcm13082204. J Clin Med. 2024. PMID: 38673476 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
